433 results
8-K
EX-99.2
LSTA
Lisata Therapeutics Inc
9 May 24
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:08pm
and Rolling Review Certepetide received Fast Track Designation from FDA for pancreatic cancer Orphan Drug Designation Incentives such as tax
8-K
EX-99.2
gy1r9i
29 Feb 24
Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.2
c28xzbbb4mmurf
2 Nov 23
Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
7s8gqzs
14 Aug 23
Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.1
ckxxz36 gb936bfhq
9 May 23
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:08pm